Product
Administration of investigation drug
1 clinical trial
1 indication
Indication
AsthmaClinical trial
Phase 3, Multicenter, Randomized, Parallel-Group, Open-Label, Comparative Non-Inferiority Fixed-Dose Combination Formoterol 6 mcg/Fluticasone 125 mcg Versus Alenia® (Formoterol 6 mcg/Budesonide 200 mcg) in the Treatment of Moderate AsthmaStatus: Not yet recruiting, Estimated PCD: 2025-06-30